| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.5 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.041 | 0.5 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.043 | 0.5 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.5 |